Literature DB >> 3974053

Autoimmune hemolytic anemia with both cold and warm autoantibodies.

I A Shulman, D R Branch, J M Nelson, J C Thompson, S Saxena, L D Petz.   

Abstract

Of 144 patients with a positive direct antiglobulin test and having autoimmune hemolytic anemia (AIHA), 12 (8.3%) satisfied diagnostic criteria for both warm antibody AIHA and cold agglutinin syndrome. All 12 patients had IgG and C3d sensitizing their erythrocytes, and samples of their serum contained IgM cold autohemagglutinins optimally reactive at 4 degrees C, but with a high thermal amplitude to 37 degrees C, and IgG warm autoantibodies. All red blood cell eluates contained IgG warm autoantibodies. The 12 patients had severe hemolytic anemia that responded dramatically to corticosteroid therapy, with the mean hemoglobin level increasing from 6.3 to 12.9 g/dL. Five patients (42%) had systemic lupus erythematosus, one patient (8%) had a non-Hodgkin's lymphoma, and six patients (50%) had idiopathic AIHA; four patients (33%) had concomitant thrombocytopenia (Evans' syndrome). Nine patients (75%) were female. Four patients had unexpected alloantibodies potentially capable of in vivo hemolysis of transfused blood. Because of the severe hemolysis, the serologic findings, and the dramatic initial clinical response to corticosteroid therapy, these patients represent a distinct catagory of AIHA and should be given corticosteroid therapy quickly.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3974053

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  14 in total

1.  A patient with mixed type Evans syndrome: efficacy of rituximab treatment.

Authors:  Chi Young Park; Choon Hae Chung
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

Review 2.  Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.

Authors:  Peter Valent; Klaus Lechner
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

3.  Look No Further: An Exercise in Clinical Reasoning.

Authors:  Patrick Rendon; Gurpreet Dhaliwal; Benjamin Kim; Alberto Aguayo; J Rush Pierce
Journal:  J Gen Intern Med       Date:  2016-04-13       Impact factor: 5.128

4.  Development of mixed-type autoimmune hemolytic anemia and Evans' syndrome following chicken pox infection in a case of low-titer cold agglutinin disease.

Authors:  Yumi Tanaka; Masahiro Masuya; Naoyuki Katayama; Eri Miyata; Yuka Sugimoto; Tetsunori Shibasaki; Kentaro Yamamura; Kohshi Ohishi; Nobuyuki Minami; Hiroshi Shiku; Tsutomu Nobori
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

5.  Tolerization of recent thymic emigrants is required to prevent RBC-specific autoimmunity.

Authors:  Andrea S L Wong; David R Gruber; Amanda L Richards; Kathryn Sheldon; Annie Qiu; Ariel Hay; Krystalyn E Hudson
Journal:  J Autoimmun       Date:  2020-06-03       Impact factor: 7.094

6.  Complement deposition in autoimmune hemolytic anemia is a footprint for difficult-to-detect IgM autoantibodies.

Authors:  Elisabeth M Meulenbroek; Masja de Haas; Conny Brouwer; Claudia Folman; Sacha S Zeerleder; Diana Wouters
Journal:  Haematologica       Date:  2015-09-09       Impact factor: 9.941

Review 7.  Treatment of autoimmune hemolytic anemias.

Authors:  Alberto Zanella; Wilma Barcellini
Journal:  Haematologica       Date:  2014-10       Impact factor: 9.941

8.  Good outcome after rituximab treatment for a mixed warm and cold autoimmune haemolytic anaemia.

Authors:  Brigitte Granel; Pascal Rossi; Fanny Bernard; Isabelle Dettori; Regis Costello; Anne Laurence Demoux; Denis Bagneres; Pierre Lafforgue; Yves Frances
Journal:  BMJ Case Rep       Date:  2009-03-06

Review 9.  The role of serological and molecular testing in the diagnostics and transfusion treatment of autoimmune haemolytic anaemia.

Authors:  Mirela Raos; Marija Lukic; Drazen Pulanic; Marijo Vodanovic; Branka Golubic Cepulic
Journal:  Blood Transfus       Date:  2021-10-15       Impact factor: 5.752

10.  Autoantigen presentation by splenic dendritic cells is required for RBC-specific autoimmunity.

Authors:  Amanda L Richards; Annie Qiu; Flavia Dei Zotti; Kathryn Sheldon; Chomkan Usaneerungrueng; David R Gruber; Krystalyn E Hudson
Journal:  Transfusion       Date:  2020-11-17       Impact factor: 3.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.